MedTrace Logo

Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial

NCT01897350 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2014-10-21

No results posted yet for this study

Summary

Cardiac magnetic resonance imaging (CMR) is a non invasive technique used to obtain functional and anatomical information on the heart. Several CMR parameters measured after primary percutaneous coronary intervention (PPCI) have been shown to have prognostic value and are increasingly being used as surrogate endpoints in clinical trials. Myocardial oedema is a prognostic indicator following myocardial infarction1. Myocardial salvage is calculated as the myocardial oedema minus infarct size; this again is a prognostic indicator following STEMI. However, myocardial oedema imaging is controversial. There are multiple sequences available, with no standardisation of sequences used to assess this surrogate endpoint. The investigators propose to conduct a study to measure the myocardial oedema by all available techniques to determine the agreement between these methods.

Conditions

  • ST Segment Elevation Myocardial Infarction
  • Myocardial Oedema

Interventions

OTHER

Cardiac magnetic resonance imaging

Sponsors & Collaborators

  • Elisa McAlindon

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01897350 on ClinicalTrials.gov